Eagle Pharmaceuticals, Inc. Share Repurchase Authorization
Eagle Pharmaceuticals, Inc. had Share Repurchase Authorization of $100.00 million as of 2017-08-09, per its 10-K filed 2020-03-02.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2020-03-02
- 2017-08-09: Stock Repurchase Program, Authorized Amount $100.00M.
- 2016-08-09: Stock Repurchase Program, Authorized Amount $75.00M.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2017-08-09 | $100.00M 10-K · filed 2020-03-02 |
| 2016-08-09 | $75.00M 10-K · filed 2020-03-02 |